Mohammad Abdullah Aljasir

4.0k total citations · 1 hit paper
31 papers, 696 citations indexed

About

Mohammad Abdullah Aljasir is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mohammad Abdullah Aljasir has authored 31 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Mohammad Abdullah Aljasir's work include Computational Drug Discovery Methods (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and vaccines and immunoinformatics approaches (3 papers). Mohammad Abdullah Aljasir is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and vaccines and immunoinformatics approaches (3 papers). Mohammad Abdullah Aljasir collaborates with scholars based in Saudi Arabia, Pakistan and Egypt. Mohammad Abdullah Aljasir's co-authors include Ameen S. S. Alwashmi, Aqel Albutti, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, Fatima Noor, Fahad A. Alhumaydhi, Ahmad Almatroudi, Mohammed A. Alsahli, Arshad Husain Rahmani and Saleh A. Almatroodi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Coordination Chemistry Reviews and FEBS Letters.

In The Last Decade

Mohammad Abdullah Aljasir

30 papers receiving 689 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network Pharmacology Approach for Medicinal Plants: Review and Assessment

2022 258 citations Fatima Noor, Muhammad Tahir ul Qamar et al. Pharmaceuticals profile →

Peers

Countries citing papers authored by Mohammad Abdullah Aljasir

Since Specialization

Citations

This map shows the geographic impact of Mohammad Abdullah Aljasir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abdullah Aljasir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abdullah Aljasir more than expected).

Fields of papers citing papers by Mohammad Abdullah Aljasir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Abdullah Aljasir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abdullah Aljasir. The network helps show where Mohammad Abdullah Aljasir may publish in the future.

Co-authorship network of co-authors of Mohammad Abdullah Aljasir

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Abdullah Aljasir. A scholar is included among the top collaborators of Mohammad Abdullah Aljasir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Abdullah Aljasir. Mohammad Abdullah Aljasir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From Quantum Chemistry to Dynamics: Exploring Potential Inhibitors for Alongshan Virus RdRp Through Advanced Computational Techniques 2025 ·Journal of Computational Biophysics and Chemistry ·(unknown), Sajjad Ahmad, Mohammad Abdullah Aljasir, (unknown), Farhan Siddique, (unknown), Bushra Rehman	0
2	Multi-scale computational modeling to identify novel chemical scaffolds as trehalose-6-phosphate phosphatase inhibitors to combat Burkholderia pseudomallei 2025 ·In Silico Pharmacology ·(unknown), Mohammad Abdullah Aljasir, (unknown), (unknown), Sajjad Ahmad, (unknown), Saifullah Khan, Farhan Siddique, (unknown), (unknown), (unknown), Muhammad Irfan, Abbas Khan, (unknown)	1
3	Organotin(IV) complexes: Emerging Frontiers in anticancer therapeutics and bioimaging applications 2025 ·Coordination Chemistry Reviews ·(unknown), Fahad A. Alhumaydhi, Waleed Al Abdulmonem, Mohammad Abdullah Aljasir, Mohammad Ibrahim	2
4	Exploring the cytoprotective role of mesenchymal stem Cell-Derived exosomes in chronic liver Fibrosis: Insights into the Nrf2/Keap1/p62 signaling pathway 2024 ·International Immunopharmacology ·(unknown), Omnia A. Badr, Arigue A. Dessouky, Ola Mostafa, (unknown), (unknown), Mohammad Abdullah Aljasir, (unknown), (unknown), Mohamed El‐Sherbiny, Rasha Hamed Al‐Serwi, Mahmoud M. Ramadan, (unknown), (unknown), Fares E.M. Ali, Nesrine Ebrahim	8
5	The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib 2024 ·FEBS Letters ·(unknown), (unknown), Mohammad Abdullah Aljasir, (unknown), (unknown), Maxine S. Emmett, (unknown), Rowan Pritchard‐Jones, Michael Cross	7
6	VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells 2023 ·Cells ·(unknown), Mohammad Abdullah Aljasir, (unknown), (unknown), (unknown), Jürgen Müller, Christopher E. Goldring, Bettina Wilm, Michael Cross	2
7	Exploring the hub genes and potential drugs involved in Fanconi anemia using microarray datasets and bioinformatics analysis 2023 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), Taghreed N. Almanaa, Mohammad Abdullah Aljasir, (unknown), Samira Sanami, (unknown), Ijaz Ali, Faisal Ahmad, Sajjad Ahmad	10
8	Unveiling promising inhibitors of superoxide dismutase 1 (SOD1) for therapeutic interventions 2023 ·International Journal of Biological Macromolecules ·Akhtar Atiya, Abdullatif Bin Muhsinah, Mohammed Alrouji, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, Mohammad Abdullah Aljasir, (unknown), Mohammad Furkan, Rizwan Hasan Khan, Moyad Shahwan, Anas Shamsi	8
9	Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice 2022 ·SHILAP Revista de lepidopterología ·Arif Khan, Mohammed A. Alsahli, Mohammad Abdullah Aljasir, Hamzah Maswadeh, (unknown), Faizul Azam, Khaled S. Allemailem, Faris Alrumaihi, Fahad A. Alhumaydhi, Ahmad Almatroudi, (unknown), Masood Alam Khan	16
10	Network Pharmacology Approach for Medicinal Plants: Review and Assessment breakdown → 2022 ·Pharmaceuticals ·Fatima Noor, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, Aqel Albutti, Ameen S. S. Alwashmi, Mohammad Abdullah Aljasir	258
11	Could allicin alleviate trastuzumab-induced cardiotoxicity in a rat model through antioxidant, anti-inflammatory, and antihyperlipidemic properties? 2022 ·Life Sciences ·(unknown), (unknown), Fahad A. Alhumaydhi, Ahmad Almatroudi, Khaled S. Allemailem, Mohammed A. Alsahli, Faris Alrumaihi, Mohammad Abdullah Aljasir, Ameen S. S. Alwashmi, Ahmed A. Ahmed, Arif Khan, Khalid Al-Regaiey, (unknown), Mahdi H. Alsugoor, (unknown), (unknown)	16
12	Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt/ b-catenin signaling pathway 2022 ·Biomedicine & Pharmacotherapy ·Nesrine Ebrahim, (unknown), (unknown), (unknown), Omnia A. Badr, Amira Hassouna, (unknown), (unknown), (unknown), (unknown), Mohammad Abdullah Aljasir, Mohamed El‐Sherbiny, (unknown), (unknown), Ola Mostafa, Dina Sabry, (unknown), Nicholas R. Forsyth, Nehal M. Elsherbiny, (unknown)	30
13	Impact of Single Amino Acid Substitutions in Parkinsonism-Associated Deglycase-PARK7 and Their Association with Parkinson’s Disease 2022 ·Journal of Personalized Medicine ·Farah Anjum, (unknown), Taj Mohammad, Alaa Shafie, Fahad A. Alhumaydhi, Mohammad Abdullah Aljasir, Moyad Shahwan, (unknown), Mohd Adnan, Abdelbaset Mohamed Elasbali, Visweswara Rao Pasupuleti, Md. Imtaiyaz Hassan	7
14	Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update 2021 ·Pharmaceutics ·Vijay Mishra, Pallavi Nayak, Mayank Sharma, Aqel Albutti, Ameen S. S. Alwashmi, Mohammad Abdullah Aljasir, (unknown), Murtaza M. Tambuwala	37
15	Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects 2021 ·Cutaneous and Ocular Toxicology ·(unknown), Fahad A. Alhumaydhi, Ahmed A. H. Abdellatif, Waleed Al Abdulmonem, (unknown), Suliman A. Alsagaby, Osamah Al Rugaie, Abdullah M. Alnuqaydan, Abdullah S. M. Aljohani, Mohammad Abdullah Aljasir, Ameen S. S. Alwashmi, (unknown), (unknown), (unknown), Ali Yousif Babiker, (unknown), Ahmed M. S. Hegazy, (unknown)	9
16	Spectroscopic, calorimetric and in silico insight into the molecular interactions of Memantine with human transferrin: Implications of Alzheimer's drugs 2021 ·International Journal of Biological Macromolecules ·Anas Shamsi, Moyad Shahwan, Fahad A. Alhumaydhi, Ameen S. S. Alwashmi, Mohammad Abdullah Aljasir, Suliman A. Alsagaby, Waleed Al Abdulmonem, Md. Imtaiyaz Hassan, Asimul Islam	23
17	Could Mesna and Celery Seed Cotherapy Modulate Oxidative Stress and Inflammation of the Urinary Bladder Induced by Ifosfamide in Rabbits? 2021 ·Journal of Inflammation Research ·(unknown), Khaled S. Allemailem, Fahad A. Alhumaydhi, Faris Alrumaihi, Ahmad Almatroudi, Ameen S. S. Alwashmi, Mohammad Abdullah Aljasir, Osamah Al Rugaie, Abdullah S. M. Aljohani, (unknown), (unknown), Ahmed M. S. Hegazy, (unknown)	3
18	Garlic Extract Alleviates Trastuzumab-Induced Hepatotoxicity in Rats Through Its Antioxidant, Anti-Inflammatory, and Antihyperlipidemic Effects 2021 ·Journal of Inflammation Research ·(unknown), (unknown), Fahad A. Alhumaydhi, Ahmad Almatroudi, Osamah Al Rugaie, Khaled S. Allemailem, Faris Alrumaihi, Arif Khan, (unknown), Mohammad Abdullah Aljasir, Ameen S. S. Alwashmi, Faris F. Aba Alkhayl, Aqel Albutti, (unknown)	7
19	CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic Program 2019 ·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy ·Thilipan Thaventhiran, Wai‐Ki Wong, Ahmad F. Alghanem, (unknown), Mohammad Abdullah Aljasir, (unknown), Swaminathan Sethu, Han Xian Aw Yeang, Amy E. Chadwick, Michael Cross, Steven D. Webb, Laiche Djouhri, (unknown), Richard Stebbings, Jean G. Sathish	3
20	RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells 2017 ·Angiogenesis ·Ahmad F. Alghanem, (unknown), Maxine S. Emmett, Mohammad Abdullah Aljasir, Katherine Holmes, (unknown), (unknown), Victoria L. Heath, Michael Cross	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact